145 related articles for article (PubMed ID: 7762602)
1. TNF modulates endothelial properties by decreasing cAMP.
Koga S; Morris S; Ogawa S; Liao H; Bilezikian JP; Chen G; Thompson WJ; Ashikaga T; Brett J; Stern DM
Am J Physiol; 1995 May; 268(5 Pt 1):C1104-13. PubMed ID: 7762602
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
[TBL] [Abstract][Full Text] [Related]
3. Cyclic nucleotide hydrolysis in bovine aortic endothelial cells in culture: differential regulation in cobblestone and spindle phenotypes.
Keravis T; Komas N; Lugnier C
J Vasc Res; 2000; 37(4):235-49. PubMed ID: 10965223
[TBL] [Abstract][Full Text] [Related]
4. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels.
Ogawa S; Koga S; Kuwabara K; Brett J; Morrow B; Morris SA; Bilezikian JP; Silverstein SC; Stern D
Am J Physiol; 1992 Mar; 262(3 Pt 1):C546-54. PubMed ID: 1312775
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
8. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
Seldon PM; Barnes PJ; Meja K; Giembycz MA
Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
[TBL] [Abstract][Full Text] [Related]
9. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
von Bülow V; Rink L; Haase H
J Immunol; 2005 Oct; 175(7):4697-705. PubMed ID: 16177117
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence.
Zheng H; Crowley JJ; Chan JC; Hoffmann H; Hatherill JR; Ishizaka A; Raffin TA
Am Rev Respir Dis; 1990 Nov; 142(5):1073-8. PubMed ID: 2173454
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production.
Meng X; Ao L; Shames BD; Harken AH
J Surg Res; 2001 Dec; 101(2):210-5. PubMed ID: 11735278
[TBL] [Abstract][Full Text] [Related]
12. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
14. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model.
Pinsky D; Oz M; Liao H; Morris S; Brett J; Sciacca R; Karakurum M; Van Lookeren Campagne M; Platt J; Nowygrod R
J Clin Invest; 1993 Dec; 92(6):2994-3002. PubMed ID: 8254053
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G
Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161
[TBL] [Abstract][Full Text] [Related]
16. Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells.
Forgèt MA; Sisson JH; Spurzem JR; Wyatt TA
Alcohol; 2003; 31(1-2):31-8. PubMed ID: 14615009
[TBL] [Abstract][Full Text] [Related]
17. Preliminary identification and role of phosphodiesterase isozymes in human basophils.
Peachell PT; Undem BJ; Schleimer RP; MacGlashan DW; Lichtenstein LM; Cieslinski LB; Torphy TJ
J Immunol; 1992 Apr; 148(8):2503-10. PubMed ID: 1373172
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability.
Seybold J; Thomas D; Witzenrath M; Boral S; Hocke AC; Bürger A; Hatzelmann A; Tenor H; Schudt C; Krüll M; Schütte H; Hippenstiel S; Suttorp N
Blood; 2005 May; 105(9):3569-76. PubMed ID: 15650061
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
20. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
